Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Aarti Drugs Limited ( (IN:AARTIDRUGS) ) is now available.
Aarti Drugs Limited has announced a scheduled quarterly earnings conference call on May 7, 2025, to discuss its financial performance for the quarter ending March 31, 2025. This call will provide investors and analysts with insights into the company’s financial health and operational strategies, potentially impacting stakeholder decisions and market perceptions.
More about Aarti Drugs Limited
Aarti Drugs Limited operates in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients, formulations, and specialty chemicals. The company serves various markets, including domestic and international sectors, by providing essential pharmaceutical products.
YTD Price Performance: -22.70%
Average Trading Volume: 17,527
Current Market Cap: 32.07B INR
Learn more about AARTIDRUGS stock on TipRanks’ Stock Analysis page.